Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Rev. méd. Chile ; 130(4): 363-367, abr. 2002. graf
Artículo en Español | LILACS | ID: lil-314917

RESUMEN

Background: Cellular immune mechanisms of the resistance to infection by T cruzi as well as the pathogenesis of Chagas disease are still controversial. Aim: To quantify and analyse the peripheral blood immune cells from chagasic and non chagasic patients by flow cytometry. Patients and methods: Peripheral blood samples were taken from 21 individuals seropositive for Chagas disease, under no specific treatment. Control samples from 21 healthy blood donors were also obtained. To quantify immune cells populations by flow cytometry, antibodies against CD3, CD4, CD8, CD16/56, CD45/14, CD19 and HLA-DR markers were used. Results: The percentage of CD8+ cells was low and the CD4+/CD8+ ratio was high in chagasic patients, compared to their non infected counterparts. No statistically significant differences in the number of CD4+, NK, B, CD4+HLADR+ and CD8+HLADR+ cells, were observed within the two groups. Conclusions: These results show that Chilean chronic chagasic patients have lower percentage of CD8+ cells and higher CD4+/CD8+ ratio than non infected individuals


Asunto(s)
Humanos , Masculino , Adulto , Femenino , Persona de Mediana Edad , Enfermedad de Chagas , Inmunofenotipificación/métodos , Trypanosoma cruzi , Linfocitos T CD4-Positivos , Estudios de Casos y Controles , Recuento de Linfocitos , Linfocitos T CD8-positivos , Citometría de Flujo/métodos
2.
Rev. méd. Chile ; 126(3): 265-70, mar. 1998. ilus, tab
Artículo en Español | LILACS | ID: lil-210573

RESUMEN

Background: Chagas disease is endemic in Chile. Allopurinol and itraconazole have activity against Trypanosoma cruzi and are recommended for the treatment of chronic disease in adults. Aim: To evaluate the chemotherapeutic effects of allopurinol and itraconazole using conventional and non conventional serologic test. Patients and methods: Sera of 90 patients with chonic Chagas disease were studied before and after 9 to 11 months of treatment with allopurinol or itraconazole and after two month of treatment with placebo. Indirect immunofluorescence, ELISA and Western Blot analysis were the conventional serologic tests used and antibody dependent complement mediated lysis (CoML) the non conventional test. Results: There were no differences in ELISA and indirect immunofluorescence tests before and after therapy. Antigenic recognition profiles by Western Blot showed qualitative and quantitative differences in a small number of cases. CoML showed that the greater negativity was achieved in the Chagasic group treated with allopurinol or itraconazole that had a negative xenodiagnosis before drugs treatment (35.8 and 61.6 percent, respectively). Conclusions: There is a reversion of lytic activity in sera of patients with negative xenodiagnosis before treatment, suggesting the parasitemia could be an important parameter to be considered in the chemotherapy of Chagas disease


Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Alopurinol , Enfermedad de Chagas/tratamiento farmacológico , Itraconazol , Técnicas In Vitro , Pruebas Serológicas/métodos , Placebos , Western Blotting , Enfermedad de Chagas/sangre , Técnica del Anticuerpo Fluorescente Indirecta , Pruebas Cutáneas/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA